{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:48:01Z","timestamp":1788306481760,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.cgh.2013.02.016","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T16:33:43Z","timestamp":1361982823000},"page":"898-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management"],"prefix":"10.1016","volume":"11","author":[{"given":"Siddharth","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant A.","family":"Talwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2013.02.016_bib1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib3","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib4","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in south Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib9","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib11","first-page":"2009","article-title":"The Nordic liver transplant registry","volume":"2012","author":"Karlsen","year":"2009","journal-title":"Annu Rep"},{"key":"10.1016\/j.cgh.2013.02.016_bib12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib13","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with nonsmoking: a case-control study","volume":"110","author":"Loftus","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.51.4.567","article-title":"Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study","volume":"51","author":"Mitchell","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib15","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/gast.1996.v110.pm8613056","article-title":"Risk of primary sclerosing cholangitis is associated with nonsmoking behavior","volume":"110","author":"van Erpecum","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpg.2011.10.009","article-title":"Pathogenesis of primary sclerosing cholangitis","volume":"25","author":"Pollheimer","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2003.11.009","article-title":"Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1","volume":"40","author":"Yang","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the tumour necrosis factor alpha \u2212308 but not the interleukin 10 \u2212627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","volume":"49","author":"Mitchell","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/gast.2001.25527","article-title":"A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis","volume":"121","author":"Satsangi","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O'Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2013.02.016_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2013.02.016_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib27","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib28","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0016-5085(90)91096-O","article-title":"Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease","volume":"98","author":"Porayko","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00054725-200501000-00009","article-title":"Primary sclerosing cholangitis","volume":"11","author":"Talwalkar","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2013.02.016_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(80)90131-6","article-title":"Clinicopathologic features of the syndrome of primary sclerosing cholangitis","volume":"79","author":"Wiesner","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.38.3.384","article-title":"Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass","volume":"38","author":"Bansi","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.149.1.6412283","article-title":"Primary sclerosing cholangitis: findings on cholangiography and pancreatography","volume":"149","author":"MacCarty","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2013.02.016_bib36","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1055\/s-2002-35830","article-title":"Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography","volume":"34","author":"Textor","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2013.02.016_bib37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.20287","article-title":"Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Talwalkar","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2013.02.016_bib41","first-page":"43","article-title":"Surgical pathology of the syndrome of primary sclerosing cholangitis","volume":"13","author":"Ludwig","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2013.02.016_bib42","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib44","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21151","article-title":"Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC","volume":"43","author":"Corpechot","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrgastro.2010.155","article-title":"Primary sclerosing cholangitis: overview and update","volume":"7","author":"Mendes","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bj\u00f6rnsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11894-009-0006-6","article-title":"Small-duct primary sclerosing cholangitis","volume":"11","author":"Bj\u00f6rnsson","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2013.02.016_bib48","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2013.02.016_bib49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib50","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2013.02.016_bib52","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib54","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib56","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3109\/00365529709011222","article-title":"Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"32","author":"Kornfeld","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib57","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib59","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib60","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib61","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib63","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","article-title":"Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study","volume":"33","author":"Joo","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2013.02.016_bib64","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cgh.2011.11.010","article-title":"Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease","volume":"10","author":"O'Toole","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib65","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.3748\/wjg.14.3497","article-title":"Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"14","author":"Sokol","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib66","first-page":"S140","article-title":"Liver transplantation for non-resectable liver metastases from colorectal cancer","volume":"18","author":"Hagness","year":"2012","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cgh.2013.02.016_bib67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease","volume":"6","author":"Halliday","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2013.02.016_bib68","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.49.5.671","article-title":"High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis","volume":"49","author":"Fleshner","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.02.016_bib69","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ibd.20384","article-title":"Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis","volume":"14","author":"Lepist\u00f6","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2013.02.016_bib70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0016-5085(86)90926-1","article-title":"Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis","volume":"90","author":"Wiesner","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2013.02.016_bib72","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cgh.2010.09.020","article-title":"Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis","volume":"9","author":"Thackeray","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2214\/ajr.150.3.571","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"150","author":"Brandt","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2013.02.016_bib75","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib76","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.pas.0000213435.99492.8a","article-title":"Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence","volume":"31","author":"Lewis","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2013.02.016_bib77","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ajg.2011.361","article-title":"Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis","volume":"107","author":"Eaton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2012.03.010","article-title":"Pruritus in chronic cholestatic liver disease","volume":"16","author":"Bunchorntavakul","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2013.02.016_bib79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2013.02.016_bib80","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","article-title":"Bone disease in patients with primary sclerosing cholangitis","volume":"140","author":"Angulo","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib81","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT: long-term follow-up and predictive factors","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2013.02.016_bib82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004836-199504000-00011","article-title":"Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis","volume":"20","author":"Jorgensen","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib83","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2013.02.016_bib84","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2011.04658.x","article-title":"Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis","volume":"33","author":"Culver","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.02.016_bib85","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2013.02.016_bib86","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib87","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2036.2011.04822.x","article-title":"Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis","volume":"34","author":"Triantos","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.02.016_bib88","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.22891","article-title":"Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-\/- mice","volume":"49","author":"Halilbasic","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2013.02.016_bib90","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib91","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"106","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib92","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00054725-201212001-00071","article-title":"Ursodeoxycholic acid and risk of colorectal neoplasia in patients with primary sclerosing cholangitis: a meta-analysis","volume":"18","author":"Singh","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2013.02.016_bib93","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.02.016_bib94","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5107(91)70618-4","article-title":"Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment","volume":"37","author":"Johnson","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2013.02.016_bib95","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00000658-198805000-00016","article-title":"Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis","volume":"207","author":"Cameron","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2013.02.016_bib96","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archsurg.1994.01420340071012","article-title":"Surgical biliary drainage in primary sclerosing cholangitis","volume":"129","author":"Myburgh","year":"1994","journal-title":"Arch Surg"},{"key":"10.1016\/j.cgh.2013.02.016_bib97","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2013.02.016_bib98","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib99","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib100","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2013.02.016_bib101","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib102","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2013.02.016_bib103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.02.016_bib104","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2013.02.016_bib105","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2013.02.016_bib106","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/0016-5085(92)91449-E","article-title":"Primary sclerosing cholangitis: refinement and validation of survival models","volume":"103","author":"Dickson","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2013.02.016_bib107","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2013.02.016_bib108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis","volume":"51","author":"Rudolph","year":"2009","journal-title":"J Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513002735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513002735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:12:27Z","timestamp":1761541947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356513002735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":108,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1542356513002735"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2013.02.016","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2013.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}